C4 Therapeutics (CCCC) Earnings Date & Reports

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patientsâ€™ lives... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CCCC is expected to report earnings to fall 6.94% to -45 cents per share on May 08

C4 Therapeutics CCCC Stock Earnings Reports

Q1'25

Est.

$-0.46

Q4'24

Est.

$-0.49

Q3'24

Beat

by $0.03

Q2'24

Est.

$-0.36

Q1'24

Missed

by $0.05

The last earnings report on February 27 showed earnings per share of -49 cents, missing the estimate of -48 cents. With 781.96K shares outstanding, the current market capitalization sits at 107.90M.

View a ticker or compare two or three

Compare

CCCC